S. Ausim Azizi, MD, PhD, Matthew T. Moore Chair and Professor of Investigative Neurology, Professor of Neurology, and Professor in the Center for Substance Abuse Research at the Lewis Katz School of Medicine at Temple University, spoke with KYW Newsradio about cluster headaches and the U.S. Food and Drug Administration’s recent approval of the medication Emgality for their treatment.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH